REPOSITORY ABOUT GUIDELINES CITING BLOG

Simulations Plus, Inc. (USA)

QsarDB Repository

Simulations Plus, Inc. (USA)

 

Simulations Plus, Inc. (https://www.simulations-plus.com/) is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. Our QSAR models in QsarDB were built by the Cheminformatics division using the ADMET Modeler™ module in ADMET Predictor®.

Collections in this community

Recent Submissions

  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_Risk Abstract The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_NIHS The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_m1535 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_m102+wp2 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_m100 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_m98 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), because ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_m97+1537 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_1535 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_102+wp2 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_100 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), because ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_98 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), because ...
  • HumanHealth Classification QMRF
    Published: Michael Lawless (2021-09-02)
    Abstract: MUT_97+1537 The Ames bacterial mutagenicity test is an important regulatory screen for potential carcinogenicity. In silico prediction of Ames positivity plays two important but somewhat distinct roles in the discovery and development of biologically active compounds. A positive Ames test does not necessarily derail development of an active ingredient (AI), ...